학술논문
Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE)
Document Type
Article
Author
Source
In International Journal of Surgery July 2022 103
Subject
Language
ISSN
1743-9191